| Literature DB >> 10400252 |
I Hozumi1, M Hiraiwa, T Inuzuka, Y Yoneoka, K Akiyama, R Tanaka, K Kikugawa, R Nakano, S Tsuji, J S O'Brien.
Abstract
The effectiveness of prosaposin as a neurotrophic factor was investigated using rats with bilateral stab wounds, injecting 240 ng per day of prosaposin for 3 days. In Morris water maze task, after 3 weeks postoperation, the stab-wounds rats show significant impairment in acquisition compared with the sham-operated rats. In the transfer test the mean number of crossings of the platform place in stab-wounds was significantly lower than that in sham-operated rats (P < 0.01). The stab-wounds rats treated with prosaposin showed significant improvement (P < 0.05). The cavities following stab wounds in the rats treated with prosaposin were significantly smaller than those in the rats treated with (P < 0.05). Our data support that prosaposin is likely to be a new agent for brain injury.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10400252 DOI: 10.1016/s0304-3940(99)00325-0
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046